Featured Journal Content

SAVE THE DATE – Developing a framework for evaluating new COVID-19 vaccines
23 February 2022 13:00 – 19:30 CET
Download Agenda
Registration: https://who-e.zoom.us/webinar/register/WN_MBB2uq8ATsiuG-V2xQSR4w
The WHO R&D Blueprint is organizing a consultation to discuss emerging evidence towards the establishment of correlates of protection for COVID-19 vaccines.  There is a global need to increase the supply of vaccines that likely meet the WHO TPP criteria for effectiveness against severe disease.
WHO is considering the development of a framework to help evaluate new vaccines, against currently circulating variants or for pan-sarbecovirus vaccines. This may also help inform researchers and developers decisions on how to generate additional data for the assessment of new vaccines.
The scientific elements of the proposed framework will be presented and discussed during this meeting.

EPI-WIN webinar: Update on COVID-19 vaccines & vaccine safety monitoring
23 February 2022 14:00 – 15:00 CET
Please join us for a technical briefing on the different types of COVID-19 vaccines and vaccine safety monitoring.
Speakers:
:: Dr. Martin Friede, Unit Head,Vaccine and Immunology Research , WHO
:: Dr Madhava Ram Balakrishnan, Medical Officer, Global Vaccine Safety, WHO
Registratoin: https://who-e.zoom.us/webinar/register/WN_L_tGfKBdSe6ENX7as9NThA

Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process 23 December 2021
[Full scale view available at title link above]
[Updated on 18 February 2022]